Schedule 13G ownership disclosure

Akers Biosciences, Inc.

Security class unavailable · CUSIP: 00973E409

Event date: 2020-04-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,885
Percent of class
0.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-20-000110
Form type
SC 13G/A
Filer
Q/C TECHNOLOGIES, INC.
CIK
CIK 1321834
Filed
May 05, 2020
Reporting period
Apr 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub